Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

Losing your sense of self is a common part of a dimethyltryptamine (DMT) trip, but what actually happens in the brain when this occurs? Researchers at Imperial College London and collaborators ...

Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...

Advanced brain imaging in a study from a team of U.K.-based scientists shows how dimethyltryptamine (DMT) alters perception of reality by changing communication and connectivity. According to a March ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...

N,N-dimethyltryptamine, more commonly known as DMT, is one of the most powerful psychedelics known to humankind. “The DMT experience is one in which people report going into a different dimension, an ...

DMT, a chemical found in ayhuasca, produces an intense roughly 20-minute trip if it's injected. Scientists say they newly understand how the drug acts on the brain from two types of imaging.

This article was originally featured on Undark. When Johannes Reckweg arrived in the Netherlands in 2016 to work on his master’s program in neuropsychology, he didn’t expect to learn about a ...

Machine Elves, the entities reported during DMT experiences, have sparked a debate: are they interdimensional aliens, or just a bad trip? Let’s dive in. Machine Elves, coined by ethnobotanist Terence ...

Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity. In a study at Imperial College London, detailed brain imaging data from 20 ...

VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB ...